We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Global Blood Gas and Electrolyte Analyzers Market to Surpass USD 2.1 Billion by 2025

By LabMedica International staff writers
Posted on 06 Nov 2019
Print article
Image: The Bench Top segment is the biggest driver to the global blood gas and electrolyte analyzers market (Photo courtesy of Market Research Business).
Image: The Bench Top segment is the biggest driver to the global blood gas and electrolyte analyzers market (Photo courtesy of Market Research Business).
The global blood gas and electrolyte analyzers market is projected to grow at a CAGR of 6.5% during the forecast period, 2018-2025 to reach a value of over USD 2.1 billion by 2025, driven mainly by the Bench Top segment which is anticipated to bring in healthy gains and add significant momentum to the market growth. The Bench Top segment is projected to grow at a CAGR of over 6.4% during the forecast period.

Geographically, several macroeconomic factors and internal market forces will shape the growth and development of demand patterns in the emerging countries in Asia-Pacific, Latin America and the Middle East. In North America, the US blood gas and electrolyte analyzers market is expected to grow at a CAGR of 5.5% during the forecast period. Within Europe, Germany is projected to add sales of over USD 64.4 million to the region’s blood gas and electrolyte analyzers market over the next 5 to 6 years. Over USD 55.9 million worth of demand in the region is projected to come from the Rest of Europe markets. In Japan, the Bench Top segment is expected to reach a market size of USD 97.6 million by the end of the forecast period.

The blood gas and electrolyte analyzers market in China, which is the world's second largest-economy and the new game changer in the global markets, is projected to grow at the rate of 9.6% over the next couple of years and add approximately USD 498.3 million in terms of addressable opportunity.


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Ultrasound-based duplex sonography combined with a new genetic testing procedure can identify clonal haematopoiesis (Photo courtesy of 123RF)

New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk

A key interest area in cardiovascular research today is the impact of clonal hematopoiesis on cardiovascular diseases. Clonal hematopoiesis results from mutations in hematopoietic stem cells and may lead... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.